| CAS Number: | 10025-73-7 |
| MDL Number: | MFCD00010948 |
| Molecular Formula: | Cl3Cr |
| Molecular Weight: | 158.35 |
| Chemical Formula: | CrCl3 |
| Color and Form: | purple flakes (< 1/8'') |
| Note: |
Stability: hygroscopic
Safety: Hazardous
Physical Characteristics: melting point ~1150°C, boiling point subl. 1300°C, density 2.76
| SECTION 1: Product Identification | |
|---|---|
| Chemical Name: | Chromium (III) chloride anhydrous (99.9%-Cr) |
| Product Number: | 93-2442 |
| CAS Registry Number: | 10025-73-7 |
| Formula: | CrCl3 |
| EINECS Number: | 233-038-3 |
| Chemical Family: | metal halide |
| Synonym: | Chromic chloride, chromium trichloride |
| SECTION 2: Composition and Information on Ingredients | ||||
|---|---|---|---|---|
| Ingredient | CAS Number | Percent | ACGIH (TWA) | OSHA (PEL) |
| Title Compound | 10025-73-7 | 100 | 0.5mg/m3 (as Cr) | 0.5mg/m3 (as Cr) |
| SECTION 3: Hazards Identification | |
|---|---|
| Emergency Overview: | Corrosive to skin, eyes and respiratory tract. Harmful if swallowed. Possible risk of harm to the unborn child, impaired fertility and irreversible effects. |
| Primary Routes of Exposure: | Ingestion, inhalation |
| Eye Contact: | Causes burns to the eyes. |
| Skin Contact: | Causes burns to the skin. May cause sensitization through skin contact. |
| Inhalation: | Inhalation causes burns to the nose, mucous membranes and respiratory tract. May cause sensitization through inhalation. |
| Ingestion: | Harmful if swallowed. Ingestion may cause damage to the mouth, throat and esophagus. |
| Acute Health Effects: | Corrosive to skin, eyes and respiratory tract. Harmful if swallowed. Possible risk of harm to the unborn child. |
| Chronic Health Effects: | Chromium and certain chromium salts are recognized carcinogens. Possible risk of impaired fertility and irreversible effects. |
| NTP: | Yes |
| IARC: | No |
| OSHA: | No |
| SECTION 4: First Aid Measures | |
|---|---|
| Eye Exposure: | Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need assistance in keeping their eye lids open. Get immediate medical attention. |
| Skin Exposure: | Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if irritation persists. |
| Inhalation: | Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance. |
| Ingestion: | Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce vomiting only if directed by medical personnel. |
| SECTION 5: Fire Fighting Measures | |
|---|---|
| Flash Point: | not applicable |
| Autoignition Temperature: | none |
| Explosion Limits: | none |
| Extinguishing Medium: | none required |
| Special Fire Fighting Procedures: | If involved in a fire, fire fighters should be equipped with a NIOSH approved positive pressure self-contained breathing apparatus and full protective clothing. |
| Hazardous Combustion and Decomposion Products: | If involved in a fire this material may emit fumes containing toxic chromium compounds |
| Unusual Fire or Explosion Hazards: | No unusual fire or explosion hazards. |
| SECTION 6: Accidental Release Measures | |
|---|---|
| Spill and Leak Procedures: | Small spills can be mixed with vermiculite or sodium carbonate and swept up. |
| SECTION 7: Handling and Storage | |
|---|---|
| Handling and Storage: | Store material in a tightly sealed bottle away from moisture. |
| SECTION 8: Exposure Controls and Personal Protection | |
|---|---|
| Eye Protection: | Always wear approved safety glasses when handling a chemical substance in the laboratory. |
| Skin Protection: | Wear protective clothing and gloves. Consult with glove manufacturer to determine the proper type of glove. |
| Ventilation: | Material may form a fine dust. If possible, handle the material in an efficient fume hood. |
| Respirator: | In the absence of adequate ventilation a respirator should be worn. The use of a respiratory requires a Respirator Protection Program to be in compliance with 29 CFR 1910.134. |
| Additional Protection: | No additional protection required. |
| SECTION 9: Physical and Chemical Properties | |
|---|---|
| Color and Form: | purple flakes (< 1/8'') |
| Molecular Weight: | 158.35 |
| Melting Point: | ~1150°C |
| Boiling Point: | subl. 1300°C |
| Vapor Pressure: | no data |
| Specific Gravity: | 2.76 |
| Odor: | none |
| Solubility in Water: | Soluble |
| SECTION 10: Stability and Reactivity | |
|---|---|
| Stability: | hygroscopic |
| Hazardous Polymerization: | no hazardous polymerization |
| Conditions to Avoid: | contact with moisture |
| Incompatibility: | Active metals |
| Decomposition Products: | none |
| SECTION 11: Toxicological Information | |
|---|---|
| RTECS Data: | Oral (rat); LD50: 1870 mg/kg. Inhalation (mouse); LD50: 31500 ug/m3/2H. Intraperitoneal (mouse); LD50: 143 mg/kg. Intravenous (mouse); LDLo: 400 mg/kg. Intramuscular (mouse); LD50: 40 mg/kg. Intravenous (rabbit); LDLo: 288 mg/kg. Administration onto the skin (guinea pig); LDLo: 202 mg/kg. Intraperitoneal (guinea pig); LDLo: 200 mg/kg. Oral (mouse); TDLo: 33600 mg/kg/12W-C. Intratesticular (rat); TDLo: 12668 ug/kg. Oral (mouse); TDLo: 84 gm/kg. Oral (mouse); TDLo: 33600 mg/kg. Intraperitoneal (mouse); TDLo: 44600 ug/kg. Intraperitoneal (mouse); TDLo: 30 mg/kg. Human Lymphocyte; Cytogenetic analysis: 2500 ug/L. Human Fibroblast; Cytogentic analysis: 100 umol/L |
| Carcinogenic Effects: | Tumorigen |
| Mutagenic Effects: | Possible mutagen |
| Tetratogenic Effects: | Possible reproductive effector |
| SECTION 12: Ecological Information | |
|---|---|
| Ecological Information: | No information available |
| SECTION 13: Disposal Considerations | |
|---|---|
| Disposal: | Dispose of according to local, state and federal regulations. |
| SECTION 14: Transportation | |
|---|---|
| Shipping Name (CFR): | Corrosive Solid, Acidic, Inorganic, N.O.S. |
| Hazard Class (CFR): | 8 |
| Additional Hazard Class (CFR): | NA |
| Packaging Group (CFR): | III |
| UN ID Number (CFR): | UN# 3260 |
| Shipping Name (IATA): | Non-hazardous |
| Hazard Class (IATA): | NA |
| Additional Hazard Class (IATA): | NA |
| Packaging Group (IATA): | NA |
| UN ID Number (IATA): | NA |
| SECTION 15: Regulatory Information | |
|---|---|
| TSCA: | Listed in the TSCA inventory |
| SARA (Title 313): | Title compound see Category Code N090 for reporting. |
| Second Ingredient: | none |
| Third Ingredient: | none |
| SECTION 16: Other Information | |
|---|---|
| Disclaimer: | The information herein is believed to be accurate and reliable as of the date compiled. However, Strem Chemicals, Inc. makes no representation, warranty, or guarantee of any kind with respect to the information contained in this document or any use of the product based on this information. |
| Preparation Date: | 3/20/2001 |
| Revision Date: | 4/21/2009 |